Member Info for Flippineck

Bella. As a former shareholder in ARM, I think your analogy is spot on.

Brilliant news. Thanks to our exceptional scientists. The science will take care of the funding.

Build it and they will come.

GLA

I believe we have now enough “ business heads” in the team to make the right decisions for us, whatever they may be.

GLA

If our technology proves to be as good as we think, then the sooner it is progressed in all suitable indications the better.

That means partnerships, licensing or any other means to quickly make progress.

I remember CC saying some time ago “nothing will be ruled out”. Therefore being bought out is an option. She has shown good judgement and management so far. IMO.

The clock is ticking. We need to raise funding from somewhere and sharpish. Big Pharma know this and will be fully aware of trial results to date.

Big Pharma face looming patent cliffs and have the problem many of us would like to have - what to do with all their cash!

If our science is as ground breaking as we believe, then Big Pharma will want to get involved. A decent deal would validate our platform. Time and timing is of the essence for them as well as us.

GLA

Exactly. If folks want to keep hopping on and off the bus, that’s up to them. The great investors buy and hold. I suggest people should not listen to advice from total strangers but believe in their own judgement.

If you believe in this company and its assets and if you believe we are in a commodity supercycle then OMI is a great bet. In my opinion only!!

Let’s hope it’s a sign of good things to come. The clock is ticking.

GLA

But will you go?

The share price will go where it wants to go regardless of your constant ramping and poor mathematics. Trader.

I think you will find 5m oz gold equates to £13.5 billion pounds.Not 32.

350? 350 what?

Plus a different date and time - now mid day.

Many thanks for sharing. Getting closer!

Any rise around 10% a day is fine by me!

CC doing exactly what she said the company would do.

Yes indeed, good spot Bella.

Karen Harrison, as the then Chief Operations Officer, was interviewed in Spotlight Series 4. She came over very well.

She was responsible for bringing much closer ties between the remotely operating Clinical Development Team and the Scientific Team, based at White City. Team building days etc.,etc.

This is another example of how CC has changed and improved the company for the better.

The removal of Vinegrad has long been hoped for by many. Karen Harrison will be a good communicator, I am sure.

GLA

Poor old Touk is just a glass half full type of person. Certainly not the voice of reason.

I recall posting before the start of this new tax year that I would be adding to my Avacta holding in my ISA for 2025. His almost immediate ( and unnecessary) response was “ oh well, the good news for you is that at least you will be limiting your loss to only another £20k”.

I invested on 7 April at 30.15 p - so , to date, a doubling of value in less than 5 months.

He knows nothing!!

Self congratulation is not an attractive trait.

Thorn. at least try to be honest with yourself.

You were forever mentioning your “ concerns” about half/ life of AVA6000, even though our scientists explained on several occasions it wasn’t an issue with dox. You were corrected many times but persisted with your FUD mode.

I suspect our scientists were looking at possible half/life issues with other warheads years ago. They said they wanted to become masters of FAP and they have certainly become that, so far as I can see.

Your arrogance in suggesting that somehow your concerns ( about a non problem) was helpful to anybody on this board or our scientists is laughable. I suggest you let it drop without embarrassing yourself further.

We have enough trolls on here without antagonising folks on the Aptamer board.

Posting the merits of Avacta on the Aptamer board isn’t a good idea in my view.

We have much to look forward to here.

GLA